Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Lupin to acquire French firm Medisol for around Rs 160 crore
Lupin to acquire French firm Medisol for around Rs 160 crore
Pharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160 crore). 
Boehringer Ingelheim Earns Breakthrough Therapy Designation for Pustular Psoriasis Drug
Boehringer Ingelheim Earns Breakthrough Therapy Designation for Pustular Psoriasis Drug
The FDA granted breakthrough therapy designation to Boehringer Ingelheim’s Spevigo (spesolimab) as a treatment to prevent flares in adults with generalized pustular psoriasis (GPP). ...
Vertex secures FDA clearance for infants’ cystic fibrosis therapy
Vertex secures FDA clearance for infants’ cystic fibrosis therapy
Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for KALYDECO (ivacaftor) to treat children with cystic fibrosis (CF) aged between one and four months. ...
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season
The Food and Drug Administration approved a first-of-its-kind RSV vaccine by pharmaceutical company GlaxoSmithKline for older adults on Wednesday, in time to help the U.S. combat RSV infections and...
Sun Pharma’s Deuruxolitinib IND Placed on Partial Clinical Hold
Sun Pharma’s Deuruxolitinib IND Placed on Partial Clinical Hold
The FDA has placed a partial clinical hold on Sun Pharma’s IND application for Deuruxolitinib (CTP-543), which was being studied in patients with alopecia areata, an autoimmune disease that inclu...
Merck agrees to build bioprocessing production plant in South Korea
Merck agrees to build bioprocessing production plant in South Korea
Merck also intends to forge partnerships in the field of bio-research with major Korean universities.
Alzheimer’s drug developed by Lilly slows cognitive decline by 35 pct
Alzheimer’s drug developed by Lilly slows cognitive decline by 35 pct
An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive decline by 35 percent in a closely watched late-stage trial, the company said on Wednesday, raising hopes for a sec...
Sanofi signs agreement worth up to $750m for Maze’s Pompe disease drug
Sanofi signs agreement worth up to $750m for Maze’s Pompe disease drug
Sanofi has signed an exclusive worldwide licensing agreement with Maze Therapeutics for its glycogen synthase 1 (GYS1) programme, including a lead candidate for Pompe disease and other glycogen sto...
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
Waking up in the middle of the night to take a pill is the onerous way patients take the world’s top-selling narcolepsy drug, Jazz Pharmaceuticals’ Xyrem.
AstraZeneca FDA vote worth potentially US$500mln annual peak sales
AstraZeneca FDA vote worth potentially US$500mln annual peak sales

AstraZeneca PLC forecasts for its major Lynparza drug are expected to be trimmed following an advisory vote against full approval in the US. 

Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
After 20 years developing technology for slow-release injectable drugs, MedinCell of France has won its first FDA approval.
FDA turns back Ascendis' hormone drug over manufacturing issues
FDA turns back Ascendis' hormone drug over manufacturing issues
After the FDA threw a wrench in Ascendis’ hypoparathyroidism drug application by flagging deficiencies in the filing, the agency has now issued a manufacturing-related complete response letter to...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand